Close this search box.

We are creating some awesome events for you. Kindly bear with us.

MIT’s Vibrating Capsule for Weight Control

Getting your Trinity Audio player ready...

Upon consuming a substantial meal, an individual’s stomach communicates with the brain through signals that generate a sensation of fullness. This physiological response is a crucial indicator, prompting the person to recognise the need to cease eating.

Notably, the stomach can convey similar signals when filled with liquids. This phenomenon underpins the standard dietary recommendation for individuals to consume a glass of water before meals, as it aids in inducing a sense of fullness. This practice aligns with strategies to promote mindful eating habits and curb overall food intake.

Image credits: Massachusetts Institute of Technology

In light of this, MIT engineers have introduced a novel approach to leveraging stomach distension for weight control by developing an ingestible capsule that induces vibrations within the stomach. These vibrations activate stretch receptors, creating a perceived sense of fullness. Administered 20 minutes before meals in animal studies, the capsule prompted the release of satiety-signaling hormones and led to a significant 40% reduction in food intake. While more research is needed to understand its impact on humans, this technology could offer a minimally invasive solution for obesity treatment.

Lead author Shriya Srinivasan, now an Assistant Professor at an international university, explains that the capsule, taken before each meal, could provide an option with fewer side effects than existing pharmacological treatments. The study, featured in Science Advances, was a collaboration between MIT and Brigham and Women’s Hospital, led by Giovanni Traverso.

The stomach’s mechanoreceptors are crucial in signalling fullness to the brain when distended. Inspired by artificially stretching these receptors through vibration, Srinivasan sought to create an illusory sense of stomach expansion. Collaborating with a lab, the researchers developed a capsule with a vibrating element about the size of a multivitamin. Powered by a small battery, the pill dissolves a gelatinous membrane upon reaching the stomach, activating the vibrating motor and stimulating mechanoreceptors.

Animal studies demonstrated that the vibrating capsule triggered mechanoreceptors, mimicking hormone release patterns observed post-meal, even during fasting. Activating the pill for 20 minutes before offering food led to a 40% reduction in food consumption, with the animals gaining weight more slowly during treatment periods. Traverso emphasised the potential of this endogenous approach to induce behavioural changes and modulate the enteric nervous system, overcoming challenges and costs associated with drug delivery.

The current design allows the pill to vibrate in the stomach for approximately 30 minutes, but the researchers plan to explore options for extended periods and wireless on-off control. Despite passing through the digestive tract within four to five days in animal studies, there were no signs of obstruction or negative impacts. This innovative approach offers an alternative to current obesity treatments, including invasive procedures like gastric bypass surgery and less widely used options such as gastric balloons.

In contrast to current medical interventions like injectable GLP-1 agonists, the vibrating capsule demonstrates the potential for increased affordability and accessibility. Shriya Srinivasan, who envisions it as a cost-effective solution, emphasised its relevance in global health settings where sophisticated or expensive treatments may not be easily accessible. The prospect of offering an economically viable and broadly available alternative holds promise for addressing obesity on a global scale.

In the future, the pivotal next phase involves scaling up manufacturing processes. This crucial step is integral to realising the full potential of the vibrating capsule in clinical applications. By optimising production capabilities, the aim is to facilitate large-scale deployment, making the technology more widely available for diverse populations. This expansion in manufacturing capacity lays the groundwork for conducting human clinical trials.

Human clinical trials represent the critical pathway to further assess the vibrating capsule’s safety, efficacy, and practical aspects. Researchers will delve into considerations such as the optimal timing and frequency of administration to ensure the capsule’s effectiveness as a weight control solution. These trials will provide invaluable insights into the capsule’s impact on diverse individuals, offering a comprehensive understanding of its potential benefits and any associated considerations.


Qlik’s vision is a data-literate world, where everyone can use data and analytics to improve decision-making and solve their most challenging problems. A private company, Qlik offers real-time data integration and analytics solutions, powered by Qlik Cloud, to close the gaps between data, insights and action. By transforming data into Active Intelligence, businesses can drive better decisions, improve revenue and profitability, and optimize customer relationships. Qlik serves more than 38,000 active customers in over 100 countries.


As a Titanium Black Partner of Dell Technologies, CTC Global Singapore boasts unparalleled access to resources.

Established in 1972, we bring 52 years of experience to the table, solidifying our position as a leading IT solutions provider in Singapore. With over 300 qualified IT professionals, we are dedicated to delivering integrated solutions that empower your organization in key areas such as Automation & AI, Cyber Security, App Modernization & Data Analytics, Enterprise Cloud Infrastructure, Workplace Modernization and Professional Services.

Renowned for our consulting expertise and delivering expert IT solutions, CTC Global Singapore has become the preferred IT outsourcing partner for businesses across Singapore.


Planview has one mission: to build the future of connected work. Our solutions enable organizations to connect the business from ideas to impact, empowering companies to accelerate the achievement of what matters most. Planview’s full spectrum of Portfolio Management and Work Management solutions creates an organizational focus on the strategic outcomes that matter and empowers teams to deliver their best work, no matter how they work. The comprehensive Planview platform and enterprise success model enables customers to deliver innovative, competitive products, services, and customer experiences. Headquartered in Austin, Texas, with locations around the world, Planview has more than 1,300 employees supporting 4,500 customers and 2.6 million users worldwide. For more information, visit


SIRIM is a premier industrial research and technology organisation in Malaysia, wholly-owned by the Minister​ of Finance Incorporated. With over forty years of experience and expertise, SIRIM is mandated as the machinery for research and technology development, and the national champion of quality. SIRIM has always played a major role in the development of the country’s private sector. By tapping into our expertise and knowledge base, we focus on developing new technologies and improvements in the manufacturing, technology and services sectors. We nurture Small Medium Enterprises (SME) growth with solutions for technology penetration and upgrading, making it an ideal technology partner for SMEs.


HashiCorp provides infrastructure automation software for multi-cloud environments, enabling enterprises to unlock a common cloud operating model to provision, secure, connect, and run any application on any infrastructure. HashiCorp tools allow organizations to deliver applications faster by helping enterprises transition from manual processes and ITIL practices to self-service automation and DevOps practices. 


IBM is a leading global hybrid cloud and AI, and consulting services provider, helping clients in more than 175 countries capitalize on insights from their data, streamline business processes, reduce costs and gain the competitive edge in their industries. Nearly 3,800 government and corporate entities in critical infrastructure areas such as financial services, telecommunications and healthcare rely on IBM’s hybrid cloud platform and Red Hat OpenShift to affect their digital transformations quickly, efficiently, and securely. IBM’s breakthrough innovations in AI, quantum computing, industry-specific cloud solutions and business services deliver open and flexible options to our clients. All of this is backed by IBM’s legendary commitment to trust, transparency, responsibility, inclusivity, and service. For more information, visit